Key points
- Severe neutropenia: ANC ≤500/µL, or expected to fall to ≤500/µL soon.
- First step: assess appearance, airway, breathing, perfusion, vital signs and mental status.
- Culture every lumen of the central line, ideally before the first antibiotic dose.
- High-risk FN: empiric monotherapy with an antipseudomonal beta-lactam such as cefepime; vancomycin is not routine.
- Hypotension or ill appearance: escalate to sepsis care and PICU and broaden antibiotics.
- Chest x-ray only for respiratory signs or symptoms.
- Persistent fever ≥96 hours in high-risk FN: evaluate for invasive fungal disease.
Definition and first assessment
For a fever assessment in a child receiving cancer therapy, severe neutropenia means an absolute neutrophil count (ANC) of 500/µL or less, or a count expected to fall to 500/µL or less soon.
The first priority is bedside: general appearance, airway, breathing, perfusion, vital signs and mental status. A child who looks unwell or is hypotensive needs immediate sepsis care and antibiotics, without waiting for laboratory results.
- Avoid rectal temperatures, suppositories and enemas: mucosal injury can let bacteria into the blood.
- Look for sites of infection: line exit site, mouth, perianal skin, lungs and skin.
- Neutropenic children may show few signs of inflammation, so a normal exam does not exclude serious infection.
Cultures and tests
- Blood cultures from every lumen of the central venous catheter at fever onset, ideally before antibiotics; a peripheral culture can be added.
- Complete blood count with differential, chemistry and a urinalysis or urine culture when it can be collected without delay.
- Chest x-ray only when there are respiratory signs or symptoms; it is not routine.
- Do not delay antibiotics to obtain tests.
Empiric antibiotics
For high-risk febrile neutropenia, start monotherapy with an antipseudomonal beta-lactam (such as cefepime or piperacillin–tazobactam) or a carbapenem. Start it as soon as possible in a clinically unstable child.
Vancomycin does not automatically accompany cefepime. Add a glycopeptide or a second gram-negative agent only for a specific reason: clinical instability, suspected resistant infection, a suspected catheter or skin infection, or high local resistance.
- Clinically unstable (hypotension, ill appearance): escalate to sepsis care and PICU, and broaden therapy with the oncology team.
- Low-risk FN: initial outpatient or oral therapy can be considered in selected children.
Persistent fever and antifungal therapy
Persistent fever alone, in a child who is clinically stable, does not require broader antibiotics. Re-examine the child and look for the cause instead.
In high-risk patients with fever lasting about 96 hours or more despite broad-spectrum antibiotics, evaluate for invasive fungal disease: chest CT, and other imaging guided by symptoms. Empiric or pre-emptive antifungal therapy is chosen with oncology and infectious diseases, depending on risk and current prophylaxis.
- In low-risk FN that is clinically well and afebrile, empiric antibiotics can be stopped at 48 hours if blood cultures stay negative, even without marrow recovery (2023 update).
- In high-risk patients not on mold-active prophylaxis, a pre-emptive antifungal approach guided by CT and biomarkers is an option (2023 update).
Common questions
What ANC defines neutropenia in febrile neutropenia?
An ANC of 500/µL or less, or one expected to fall to 500/µL or less soon.
Does every child with febrile neutropenia need vancomycin?
No. Empiric monotherapy with an antipseudomonal beta-lactam such as cefepime is standard. Vancomycin is added only for a specific indication, such as instability or a suspected line or skin infection.
Why avoid rectal temperatures in children with cancer?
Rectal temperatures, suppositories and enemas can injure fragile mucosa and let bacteria into the blood in a neutropenic child.
Study this topic
Sources
- Guideline for fever and neutropenia in pediatric patients with cancer and HCT recipients: 2023 update (J Clin Oncol)
- IDSA 2010: Antimicrobial agents in neutropenic patients with cancer (Clin Infect Dis)
Written for Pedemy in our own words from the sources above; checked November 2026. For education only, not medical advice; check doses and local protocols before treating a patient. Pedemy is independent and not affiliated with or endorsed by the organizations cited.